Relapsed or refractory Hodgkin lymphoma - brentuximab (failed autologous stem cell transplant (ASCT) or is ASCT naïve) initial PBS authority form (PB205)
Use this form to apply for initial PBS subsidised treatment with brentuximab vedotin for relapsed or refractory Hodgkin lymphoma and who has failed ASCT or is ASCT naïve.
This PDF is fillable. You can fill it out on your device, or print it and complete it by hand.
If you have a disability or impairment and use assistive technology, you may not be able to access our forms. If you can’t, please contact us. We can help you access, complete and submit them.
Page last updated: 1 October 2020
This information was printed 15 January 2021 from https://www.servicesaustralia.gov.au/organisations/health-professionals/forms/pb205. It may not include all of the relevant information on this topic. Please consider any relevant site notices at https://www.servicesaustralia.gov.au/individuals/site-notices when using this material.